Relative Risk of Hypertension Among Obese

• Sponsor: Ziauddin University (Other)
• Overall Status: Completed
• CT.gov ID: NCT04686513
• Collaborator: (none)
• Enrollment: 1,149
• Location: 1
• Actual Duration (Months): 13.7
• Patients Per Site Per Month: 83.9

Study Details

Study Description

Brief Summary

Observational study was conducted to determine the relative risk of hypertension among young adult obese population of Pakistan with age between 25-40 years

Condition or Disease	Intervention/Treatment	Phase
Obesity	Other: Observation

Study Design

• Study Type: Observational
• Actual Enrollment: 1149 participants
• Observational Model: Other
• Time Perspective: Cross-Sectional
• Official Title: Relative Risk of Hypertension Among Young Adult Obese Population
• Actual Study Start Date: Oct 10, 2019
• Actual Primary Completion Date: Nov 2, 2020
• Actual Study Completion Date: Nov 30, 2020

Arms and Interventions

Arm	Intervention/Treatment
Obese young adult	Other: Observation; observational study
Non Obese young adult	Other: Observation; observational study

Outcome Measures

Primary Outcome Measures

1. Hypertension [day 1]

   International Society of Hypertension Global Hypertension Practice Guidelines 2020

Eligibility Criteria

Criteria

• Ages Eligible for Study: 25 Years to 40 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

Adult population with age between 25- 40 years having normal weight or Obesity of grade I and II, with or without hypertension.

Exclusion Criteria:

Patients with co-morbid like Diabetes mellitus, dyslipidemia, and cardiovascular disorder were excluded from the study

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Batool Hassan	Karachi	Sindh	Pakistan	75600

Sponsors and Collaborators

• Ziauddin University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Batool Hassan, Principal Investigator, Ziauddin University
• ClinicalTrials.gov Identifier: NCT04686513
• Other Study ID Numbers: Batool
• First Posted: Dec 28, 2020
• Last Update Posted: Dec 28, 2020
• Last Verified: Dec 1, 2020

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Hypertension

Study Results

No Results Posted as of Dec 28, 2020